InfuSystems Holdings Price To Sales vs. Net Income

INFU Stock  USD 9.34  -0.05  -0.53%   
Based on InfuSystems Holdings' profitability indicators, InfuSystems Holdings is performing exceptionally well at this time. It has a great probability to showcase excellent profitability results in April. Profitability indicators assess InfuSystems Holdings' ability to earn profits and add value for shareholders.
Price To Sales Ratio is dropping compared to historical levels. InfuSystems Holdings reported 1.29 in Price To Sales Ratio for the previous period. Pretax Profit Margin is advancing compared to historical levels. InfuSystems Holdings reported 0.07 in Pretax Profit Margin for the previous period. As of March 13th, 2026, Operating Profit Margin is estimated to rise to 0.09, whereas Gross Profit is moving lower toward slightly above 50.9 M.

InfuSystems Holdings Price To Sales Ratio

2.12
Price To Sales Ratio is dropping compared to historical levels. InfuSystems Holdings reported 1.29 in Price To Sales Ratio for the previous period. As of March 13th, 2026, Days Sales Outstanding is estimated to rise to 77.88, whereas EV To Sales is moving lower toward 1.23.. Accumulated Other Comprehensive Income is advancing compared to historical levels. InfuSystems Holdings reported 565,000 in Accumulated Other Comprehensive Income for the previous period. As of March 13th, 2026, Operating Income is estimated to rise to approximately 12.5 M, whereas Non Operating Income Net Other is moving lower toward slightly above -147.3 K.. Pretax Profit Margin is advancing compared to historical levels. InfuSystems Holdings reported 0.07 in Pretax Profit Margin for the previous period. As of March 13th, 2026, Operating Profit Margin is estimated to rise to 0.09, whereas Gross Profit is moving lower toward slightly above 50.9 M.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.70.5598
Significantly Up
Slightly volatile
Profitability metrics here describe how InfuSystems Holdings converts revenue and assets into earnings and performance context.

Revenue Breakdown by Segment for InfuSystems Holdings

Risk vs Return Analysis.
To learn how to invest in InfuSystems Stock, please use our How to Invest in InfuSystems Holdings guide.Consensus EPS for InfuSystems Holdings is 0.11, with bounds of 0.10 and 0.12. EPS TTM is 0.31. EPS is most informative when read together with margin stability and cash-flow conversion. Consensus EPS estimates for InfuSystems Holdings typically reference EPS before non-recurring items. The consensus may include employee stock option expense.
Macro event markers
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
InfuSystems Holdings is projected to report an EPS estimate of 0.11 on 30th of June 2026. Analyst consensus for InfuSystems Holdings is presented with historical volatility context..

InfuSystems Holdings Revenue Breakdown by Earning Segment Details

Earnings estimates provide context for forward-looking performance discussion. The estimates are presented as context for broader analysis and timeframe comparison.
 Quarterly Earnings Growth
1.239
 Earnings Share
0.31
 Revenue Per Share
6.943
 Quarterly Revenue Growth
0.07
 Return On Assets
0.0669
The market value of InfuSystems Holdings is measured differently than book value, which reflects InfuSystems accounting equity. InfuSystems Holdings' market capitalization is 190.96 M. With a P/B ratio of 3.39, the market values InfuSystems Holdings well above its book equity. Enterprise value stands at 214.13 M. Value and price for InfuSystems Holdings are related but not identical, and they can diverge across cycles. Trading price represents the transaction level agreed by market participants.
Note that InfuSystems Holdings' intrinsic value and market price are different measures derived from different inputs. For InfuSystems Holdings, key inputs include a P/E ratio of 10.72, a P/B ratio of 3.39, a profit margin of 4.62%, and ROE of 11.54%. Market price reflects the current exchange level formed by active bids and offers.

InfuSystems Holdings Net Income vs. Price To Sales Fundamental Analysis

Comparative market metrics assess InfuSystems Holdings's pricing relative to peers.
InfuSystems Holdings is rated below average in price to sales relative to competitors. It maintains a third standing in net income relative to competitors yielding 4,977,841 of Net Income per Price To Sales. Price To Sales Ratio is dropping compared to historical levels. InfuSystems Holdings reported 1.29 in Price To Sales Ratio for the previous period. Comparative pricing ratios position InfuSystems Holdings within industry norms.

InfuSystems Net Income vs. Price To Sales

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

InfuSystems Holdings

P/S

 = 

MV Per Share

Revenue Per Share

 = 
1.33 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

InfuSystems Holdings

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
6.63 M
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.

InfuSystems Net Income Comparison

InfuSystems Holdings is currently under evaluation in net income relative to competitors.

InfuSystems Holdings Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in InfuSystems Holdings, profitability is also one of the essential criteria for including it into their portfolios because, without profit, InfuSystems Holdings will eventually generate negative long term returns. The profitability progress is the general direction of InfuSystems Holdings' change in net profit over the period of time. It can combine multiple indicators of InfuSystems Holdings, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income565 K593.2 K
Operating Income11.9 M12.5 M
Net Income6.6 MM
Income Tax Expense-4 M-3.8 M
Income Before Tax10.6 M11.2 M
Total Other Income Expense Net-1.3 M-1.4 M
Net Income Applicable To Common Shares20.7 K21.7 K
Net Income From Continuing Ops6.6 MM
Non Operating Income Net Other-140.3 K-147.3 K
Interest Income2.2 M1.7 M
Net Interest Income-1.3 M-1.4 M
Change To Netincome3.3 M3.1 M
Net Income Per Share 0.32 0.34
Income Quality 3.68 3.50
Net Income Per E B T 0.62 1.08

InfuSystems Profitability Driver Comparison

Profitability drivers for InfuSystems Holdings are the financial and operational factors that most directly influence its earnings. Investors must contend with a wide range of external shocks - from regulatory changes to commodity price swings - that can disrupt InfuSystems Holdings' financial results.

Earnings Estimation Breakdown

For InfuSystems Holdings, the next projected earnings per share is 0.11 based on current analyst consensus. The range of individual analyst forecasts runs from 0.1 to 0.12, reflecting varying views on InfuSystems Holdings' near-term business performance. Consensus EPS excludes non-recurring items and is calculated from trailing twelve-month operating results.
Last Reported EPS
0.0
0.10
Lowest
Expected EPS
0.11
0.12
Highest

Earnings Projection Consensus

If consensus earnings estimates imply a fair value above InfuSystems Holdings' current price, the market may be discounting future earnings more aggressively than analysts. If the market price is ahead of the estimate, the implied premium may require strong execution to sustain. These valuation signals are best used as one input within a multi-method investment framework.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 30th of June 2026Current EPS (TTM)
564.24%
0.0
0.11
0.31

Earnings History

Professional analyst coverage of InfuSystems Holdings synthesizes management guidance, sector trends, and macro assumptions into a consensus EPS estimate. This consensus shapes investor expectations ahead of each earnings release and becomes the reference point for post-report reaction. We recommend reviewing consensus alongside fundamental valuation models before making allocation decisions.

InfuSystems Holdings Quarterly Gross Profit

20.43 Million
Earnings Yield are advancing compared to historical levels. InfuSystems Holdings reported 0.04 in Earnings Yield for the previous period. As of March 13th, 2026, Price Earnings To Growth Ratio is estimated to rise to 0.15, whereas Retained Earnings are moving lower toward slightly above -63.7 M. As of March 13th, 2026, Common Stock Shares Outstanding is estimated to rise to approximately 22 M. Also, Net Income Applicable To Common Shares is estimated to rise to approximately 21.7 K.
Mean reversion in InfuSystems Holdings' price occurs when temporary dislocations - caused by sentiment extremes, news events, or liquidity shocks - correct back toward the stock's historical fair value.
Hype
Prediction
LowEstimatedHigh
6.129.3412.56
Details
Intrinsic
Valuation
LowRealHigh
8.7211.9415.16
Details
Naive
Forecast
LowNextHigh
6.039.2512.47
Details
4 Analysts
Consensus
LowTargetHigh
13.5614.9016.54
Details
A rigorous investment case for InfuSystems Holdings requires more than studying its own financials. Benchmarking InfuSystems Holdings' performance, valuation, and risk profile against competitors is essential to validate any investment thesis. The market impact of institutional consensus-following in InfuSystems Holdings means that EPS surprise size matters as much as direction. Large banks and funds that track the same analyst models often exit or accumulate simultaneously on surprise events. This synchronization amplifies short-term moves and reinforces the importance of monitoring consensus accuracy for InfuSystems.

Earnings per Share Projection vs Actual

For InfuSystems Holdings, actual EPS provides a historical record of per-share profitability that investors use to identify trends. Expected EPS for InfuSystems Holdings projects this figure forward using guidance, industry dynamics, and financial analysis. The higher InfuSystems Holdings' EPS trajectory, the stronger its implied earnings quality relative to peers.

Estimated Months Earnings per Share

Investors seeking income from InfuSystems Holdings should track EPS trends alongside dividend history to assess payout sustainability. EPS that outpaces dividend growth signals expanding coverage; EPS that lags dividend growth raises cut risk. Always complement EPS analysis with a review of operating leverage, working capital trends, and competitive positioning.

Quarterly Analyst Estimates and Surprise Metrics

EPS surprise events for InfuSystems Holdings' have historically correlated with short-term return outliers - both upside and downside. The post-earnings drift effect means that initial surprise reactions can persist over subsequent trading sessions. Analyst estimates contributing to consensus are derived from fundamental models trained on trailing performance and management guidance.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
null
nullnullnullnull
2026-03-18
2025-12-310.070.10.0342 
2025-11-04
2025-09-300.080.110.0337 
2025-08-05
2025-06-300.060.120.06100 
2025-05-07
2025-03-31-0.030.10160.1316438 
2025-03-12
2024-12-310.060.07050.010517 
2024-11-07
2024-09-300.060.080.0233 
2024-08-08
2024-06-300.040.03-0.0125 
2024-05-09
2024-03-310.02-0.05-0.07350 
2024-03-14
2023-12-310.020.0033-0.016783 
2023-11-07
2023-09-300.030.030.0
2023-08-03
2023-06-300.02670.02-0.006725 
2023-05-04
2023-03-310.02-0.02-0.04200 
2023-03-15
2022-12-310.040.01-0.0375 
2022-11-08
2022-09-300.010.020.01100 
2022-08-04
2022-06-30-0.01-0.010.0
2022-05-05
2022-03-31-0.03-0.020.0133 
2022-02-10
2021-12-310.070.02-0.0571 
2021-11-15
2021-09-300.03-0.02-0.05166 
2021-08-12
2021-06-300.080.04-0.0450 
2021-05-06
2021-03-310.040.03-0.0125 
2021-03-17
2020-12-310.060.490.43716 
2020-11-12
2020-09-300.040.140.1250 
2020-08-13
2020-06-300.020.190.17850 
2020-05-14
2020-03-31-0.02-0.020.0
2015-05-12
2015-03-310.060.05-0.0116 
2015-03-09
2014-12-310.050.050.0
2014-11-10
2014-09-300.050.04-0.0120 
2014-08-01
2014-06-300.040.040.0
2014-05-05
2014-03-310.030.030.0
2014-03-11
2013-12-310.030.040.0133 
2013-11-12
2013-09-300.020.030.0150 
2013-08-13
2013-06-300.010.0048-0.005252 
2013-05-13
2013-03-310.010.0023-0.007777 
2013-03-28
2012-12-310.020.01-0.0150 
2012-03-15
2011-12-310.010.020.01100 
2011-11-10
2011-09-3000.330.33
2011-08-11
2011-06-3000.010.01
2011-05-12
2011-03-310-0.01-0.01
2011-03-10
2010-12-310.01-0.1-0.111100 
2010-11-09
2010-09-300.010.010.0
2010-08-05
2010-06-300.020.01-0.0150 
2010-05-04
2010-03-310.01-6.0E-4-0.0106106 
2008-08-05
2008-06-300.01-0.04-0.05500 
2008-03-18
2007-12-31-0.01-0.11-0.11000 

Use InfuSystems Holdings in pair-trading

Pair trading with InfuSystems Holdings can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.

InfuSystems Holdings Pair Trading

InfuSystems Holdings Pair Trading Analysis

Using correlated positions as InfuSystems Holdings substitutes during tax-loss harvesting allows investors to capture a tax benefit without disrupting portfolio allocation. The key is finding instruments that track InfuSystems Holdings closely enough to maintain equivalent risk and return.
The correlation of InfuSystems Holdings with other assets is a key diversification metric. Pairing InfuSystems Holdings with uncorrelated or negatively correlated instruments can reduce overall portfolio volatility without necessarily reducing expected returns.
Correlation analysis and pair trading evaluation for InfuSystems Holdings can be used to frame hedging context. The view can be extended across sectors or other related groups.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your InfuSystems Holdings position

Using InfuSystems Holdings inside a theme workflow gives investors a structured way to compare related stocks, funds, ETFs, and crypto assets before allocating capital. The practical benefit is that the selected idea can be tuned either for higher upside or for tighter risk control.

Did You Try This Idea?

Run Semiconductor Thematic Idea Now

Semiconductor
Semiconductor Theme
Companies involved in production of semiconductor and semiconductor materials. The Semiconductor theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Semiconductor Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for InfuSystems Stock Analysis

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device